1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Florida >
  6. Fibronostics Acquires Stone

M&A Deal Summary

Fibronostics Acquires Stone

On October 27, 2025, Fibronostics acquired life science company Stone

Acquisition Highlights
  • This is Fibronostics’ 1st transaction in the Life Science sector.
  • This is Fibronostics’ 1st transaction in the United States.
  • This is Fibronostics’ 1st transaction in Florida.

M&A Deal Summary
Date 2025-10-27
Target Stone
Sector Life Science
Buyer(s) Fibronostics
Deal Type Add-on Acquisition

Target

Stone

Santa Rosa Beach, Florida, United States
Stone is a provider of advanced laboratory services with expertise in molecular and pathology services. Stone is based in Santa Rosa Beach, Florida.

Search 215,058 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Fibronostics

Singapore, Singapore
Category Company
Sector Life Science
DESCRIPTION

Fibronostics is a global health technology company specializing in non-invasive diagnostic solutions for chronic diseases, with a focus on liver and metabolic disorders. Fibronostics is based in Singapore, Singapore.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Florida M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2025 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal